Baylor Research Institute
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Baylor Research Institute sits in the top decile of US sponsors by registered trial count (#167 of 15,742 sponsors by registered trial count).
Baylor Research Institute: 180 sponsored US clinical trials, 31 recruiting.
Baylor Research Institute sponsors 180 registered US clinical trials on ClinicalTrials.gov, 31 of them currently recruiting, and 103 completed. 13 of these trials are in Phase 3-4 (later-stage) and 33 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 5 trials.
Top-decile sponsor footprint
Baylor Research Institute ranks in the top decile of sponsors by registered trial count (#167 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
103 of 125 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
180 total, page 2 of 4
Tacrolimus in Pregnancy
NCT07422012
Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial
NCT07467720
Intraoperative CO₂ (Carbon Dioxide)
NCT07592468
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
NCT07547878
Implementation of an Evidence-Based Educational Resource for Children With Mild Traumatic Brain Injury
NCT07414303
This Study Will Evaluate the Safety and Potential Complications of Dual ProGlide vs Single ProGlide and Angioseal for Common Femoral Arteriotomy Closure Following Transcatheter Aortic Valve Replacement
NCT06983938
Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminophen and Ibuprofen?
NCT06505148
The Role of Social Determinants in Cardiovascular Health and Vascular Function
NCT05772221
Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use- Electronic Spanish Platform
NCT05476588
Outcomes of Once-Daily ICS/LABA/LAMA + PRN Respiratory Therapy Treatments in Hospitalized Patients With COPD Exacerbations
NCT05292053
Exercise in Adults with Post-Acute Sequelae of SARS-CoV-2 (COVID-19) Infection Study
NCT05218174
Prospective Evaluation of Neurocognition in Patients Undergoing Transcatheter Aortic Valve Replacement
NCT05614986
COSMED K5 Validation and Reliability Study
NCT05145192
Foundational Ingredients of Robotic Gait Training for People With Spinal Cord Injury During Inpatient Therapy
NCT04781621
The Integrated Population (I-POP) Health Trial
NCT04761016
Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™
NCT04676061
Effects of Face Masks During Exercise
NCT04833010
Prehab Prior to Undergoing Tricuspid Intervention
NCT04665583
Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers
NCT04333225
DIstal vs Proximal Radial Artery Access for Cath
NCT04318990
Giving a Low Carbohydrate Diet to Overcome Hypertension
NCT04230928
Sternal Block With Liposomal Bupivacaine vs. Saline Prior to Incision in Cardiac Surgery
NCT04333095
Standardized Vascular Rehabilitation Program to Improve Patient Disease and Quality of Life
NCT04335695
Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients
NCT04199715
GamePlan4Care: Online Support for Family Caregivers
NCT04540198
LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer
NCT04032080
TAS-102 in Extrapulmonary Neuroendocrine Carcinoma
NCT04042714
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
NCT03817931
Management of Antiplatelet Regimen During Surgical Procedures
NCT03981835
Building an Evidence Base for Weight Loss Strategies Among Those With Chronic SCI-The GLB-SCI+
NCT03874988
Cardiorenal Protective Diet
NCT04117204
TAPS-ESP: Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use Electronic Spanish Platform
NCT03879785
DWIBS-MRI: An Adjunct to the Traditional Diagnostic Breast Imaging Evaluation
NCT04491864
Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer
NCT03622385
Nitrous Oxide for Analgesia During Office Urethral Bulking
NCT03847922
PEEZY Midstream Urine Device Compared to Catheterized Urine Sample
NCT03729336
Reducing Chronic Kidney Disease Burden in an Underserved Population
NCT03832166
Natural History of the Leukodystrophies
NCT02843555
Virtual Reality and tACS for Performance Enhancement
NCT03636126
Feasibility of Endovascular Repair of Ascending Aortic Pathologies
NCT03322033
A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children
NCT04002531
The SEEA (SCI Energy Expenditure and Activity) Study
NCT04748835
Indirect Calorimetry Usage and Effect in Ventilator-free Days and Muscle Thickness in Septic Ventilated Patients
NCT03440593
Shear Wave Elastography
NCT04493346
Outcomes After Spinal Cord Injury (OASIS)
NCT03624218
Curcumin in Combination With 5FU for Colon Cancer
NCT02724202
Pilot Study To Investigate Targetable Metabolic Pathways Sustaining Triple Negative Breast Cancer
NCT03457779
Exploration and Determination of Genomic Markers Predictive of Uterine Atony
NCT03413917
Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen
NCT03373227
Improved Patient Safety Through Continuous Bi-channel RR and SpO2 Monitoring With Masimo Patient SafetyNet
NCT03043911
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 19 |
| Phase 2 | 14 |
| Phase 3 | 2 |
| Phase 4 | 11 |
Therapeutic Areas
What is open in the Baylor Research Institute pipeline
31 recruiting of 180 indexed (17% open); 103 completed (57%).
Phase mix: 13 late (III/IV) vs 33 early (I/II) (early-phase heavy).
Top condition: Stroke (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Baylor Research Institute: open-pipeline peers nationwide
Peers matched on 180 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Baylor Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 180 trials (± recruiting share)
- Abbott · 181 trials · 0% recruiting
- ViiV Healthcare · 182 trials · 4% recruiting
- UConn Health · 178 trials · 11% recruiting
- Fox Chase Cancer Center · 183 trials · 16% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Emory University · 17% recruiting · 1,208 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Baylor Research Institute page
180 registered trials is a research-attention snapshot, not an endorsement of Baylor Research Institute or any single study.
- 31 of Baylor Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Baylor Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Baylor Research Institute pipeline card: 180 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.